Datavant _ BlueBlack (3) (1).png
Datavant Launches International Expansion, Acquires Convenet to Build Trial Tokenization in the UK
07 sept. 2022 09h00 HE | Datavant
Datavant launches international expansion and acquires Convenet, a health technology infrastructure company in the UK that has built the world’s first NHS approved API powering integration into the...
Meticulous Logo.png
Real-world Evidence (RWE) Analytics Market Worth $2.93 Billion by 2029 - Exclusive Report by Meticulous Research®
23 juin 2022 10h00 HE | Meticulous Market Research Pvt. Ltd.
Redding, California, June 23, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, 'Real-world Evidence Analytics Market by Application [Market Access & Reimbursement,...
Medi Tech Insights Logo.jpg
Global Real-World Evidence (RWE) Solutions market estimated close to $1 billion (2020), is growing at a lucrative rate of 15%
07 mars 2022 08h30 HE | Medi-Tech Insights
BRUSSELS, Belgium, March 07, 2022 (GLOBE NEWSWIRE) -- Summary: Medi-Tech Insights: We present an interesting report on Global Real-World Evidence (RWE) Solutions market. Description: RWE is...
visiongain Logo.png
Real-World Evidence Market Forecast 2020 - 2030: Visiongain Research Inc
11 nov. 2021 11h00 HE | Visiongain Ltd
Visiongain has published a new report on “Real-World Evidence Market Report Forecast 2020-2030”. Forecasts by Component (Data Sets, Services), Datasets (Clinical Settings Data, Claims Data, Pharmacy...
PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma
13 mai 2021 16h02 HE | PRA Health Sciences, Inc.
RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma®, PRA’s proprietary technology that allows...
Logo (3).png
Real-World Evidence (RWE) Solutions Market Worth $1.64 Billion by 2024, Growing at a CAGR of 15% from 2019- Market Opportunity Analysis and Industry Forecasts by Meticulous Research®
23 juin 2020 13h19 HE | Meticulous Market Research Pvt. Ltd.
London, June 23, 2020 (GLOBE NEWSWIRE) -- With the growing need to achieve better value for healthcare, the importance of real-world evidence (RWE) as a decision-making tool and an important part of...
Tempus Launches COVID-19-Specific Clinical and Research Initiatives for Oncology
30 mai 2020 10h30 HE | Tempus
CHICAGO, May 30, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, introduced a series of...
logo big square.png
Syapse, FDA, and Advocate Aurora Health to Present Pneumonitis Safety Data in Plenary Talk at AACR Virtual Meeting
27 avr. 2020 08h00 HE | Syapse
Data presented demonstrates that patients with a past medical history of pneumonitis had a higher incidence of treatment associated pneumonitis in both clinical trial and real-world data AACR Virtual...
logo big square.png
Syapse Appoints Dr. Thomas D. Brown as Chief Medical Officer
16 oct. 2019 08h26 HE | Syapse
SAN FRANCISCO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Syapse today announced the appointment of Thomas D. Brown, MD, MBA as its first Chief Medical Officer. Dr. Brown, an internationally renowned...
logo big square.png
Syapse Appoints Fletcher Payne as Chief Financial Officer
10 sept. 2019 08h00 HE | Syapse
SAN FRANCISCO, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Syapse, a company accelerating precision medicine through insights derived from its global health system network, today announced that Fletcher...